...
首页> 外文期刊>Diabetes >Portal Vein Glucose Sensors Do Not Play A Major Role Inmodulating Physiological Responses To Insulin-induced Hypoglycemia In Humans
【24h】

Portal Vein Glucose Sensors Do Not Play A Major Role Inmodulating Physiological Responses To Insulin-induced Hypoglycemia In Humans

机译:门静脉葡萄糖传感器在调节人体对胰岛素诱导的低血糖的生理反应中不发挥主要作用

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE-Experimental data from animal studies indicate that portal vein glucose sensors play a key role in the responses to slow-fall hypoglycemia. However, their role in modulating these responses in humans is not well understood. The aim of the present study was to examine in humans the potential role of portal vein glucose sensors in physiological responses to insulin-induced hypoglycemia mimicking the slow fall of insulin-treated diabetic subjects.rnRESEARCH DESIGN AND METHODS-Ten nondiabetic subjects were studied on two different occasions during intravenous insulin (2 mU · kg~(-1)· min~(-1)) plus variable glucose for 160 minutes. In both studies, after 60 min of normal plasma glucose concentrations, hypoglycemia (47 mg/dl) was induced slowly (60 min) and maintained for 60 min. Hypoglycemia was preceded by the ingestion of either oral placebo or glucose (28 g) given at 30 min.rnRESULTS-Plasma glucose and insulin were not different with either placebo or glucose (P > 0.2). Similarly, counterregulatory hormones, substrates, and symptoms were not different with either placebo or glucose. The Stroop color and colored words subtest of the Stroop test deteriorated less (P < 0.05) with glucose than placebo.rnCONCLUSIONS-In contrast to animals, in humans, prevention of portal hypoglycemia with oral glucose from the beginning of insulin-induced slow-fall hypoglycemia has no effect on sympa-thoadrenal and symptomatic responses to hypoglycemia.
机译:来自动物研究的客观实验数据表明,门静脉葡萄糖传感器在对慢速降血糖反应中起关键作用。但是,它们在调节人类这些反应中的作用还没有被很好地理解。本研究的目的是研究人类门静脉葡萄糖传感器在模仿胰岛素治疗的糖尿病患者缓慢下降对胰岛素诱导的低血糖的生理反应中的潜在作用。研究设计和方法:对十个非糖尿病患者进行了两个研究静脉注射胰岛素(2 mU·kg〜(-1)·min〜(-1))加可变葡萄糖160分钟。在两项研究中,正常血糖浓度60分钟后,均会缓慢(60分钟)诱发低血糖症(47 mg / dl),并维持60分钟。低血糖发生前,在30分钟时摄入口服安慰剂或葡萄糖(28 g)。结果-血浆葡萄糖和胰岛素与安慰剂或葡萄糖无差异(P> 0.2)。同样,安慰剂或葡萄糖对调节激素,底物和症状的影响也没有不同。 Stroop测试的Stroop颜色和有色单词子测试与安慰剂相比,葡萄糖的恶化更少(P <0.05)。结论-与动物相反,在人类中,从胰岛素引起的缓慢下降开始,口服葡萄糖预防门脉低血糖症低血糖对低血糖的象征肾上腺和症状反应没有影响。

著录项

  • 来源
    《Diabetes 》 |2009年第1期| 194-202| 共9页
  • 作者单位

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

    Department of Internal Medicine, University of Perugia, Perugia, Italy;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号